ENDLOS-TURBO PUT - AMGEN | Market Closed - Boerse Frankfurt Warrants 03:34:45 2024-05-24 pm EDT | ||
| 10.05 EUR | +0.40% |
|
| Current month | -24.76% | ||
| 1 month | -25.09% |
Comparison chart between the derivative product and it's underlying value
End-of-day quotes
Chart
AMGEN INC.
Latest news about AMGEN INC.
| Date | Price | Change |
|---|---|---|
| 24-05-24 | 10 | -0.10% |
| 24-05-23 | 10.01 | +4.93% |
| 24-05-22 | 9.54 | +3.70% |
| 24-05-21 | 9.2 | -1.60% |
| 24-05-20 | 9.35 | -0.64% |
Real-time Boerse Frankfurt Warrants
Last update May 24, 2024 at 03:34 pm EDT
More quotesStatic data
| Product type | Knock-Out without Stop Loss |
|---|---|
| Buy / Sell | PUT |
| Underlying | AMGEN INC. |
| Issuer | DZ BANK |
| WKN | DJ75SD |
| ISIN | DE000DJ75SD8 |
| Date issued | 2024-01-04 |
| Strike | 414.2 $ |
| Maturity | Unlimited |
| Parity | 10 : 1 |
| Emission price | 10.86 € |
| Emission volume | N/A |
| Settlement | cash |
| Currency | EUR |
Technical Indicators
| Highest since issue | 14.57 € |
|---|---|
| Lowest since issue | 8.19 € |
Company Profile
Amgen Inc. is one of the world's leading biotechnology groups. Net sales break down by source of revenue as follows:
- drug sales (94.2%): drugs for treating cancer, metabolic disorders, bone diseases, renal failure, hemophilia, etc.;
- other (5.8%): primarily royalties.
The United States account for 70.3% of net sales.
Sector
-
Consensus: Amgen Inc.
Sell
Buy
Mean consensus
OUTPERFORM
Number of Analysts
30
Last Close Price
305.8
USD
Average target price
316.3
USD
Spread / Average Target
+3.41%
- Stock Market
- Certificates
- Certificat
